Massimo Scheibel
Impact in
-
- Breast Cancer Treatment Studies
-
- Global Cancer Incidence and Screening
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
- Vascular Tumors and Angiosarcomas
Papers in ⓘ
- Oncology 11
- Global Cancer Incidence and Screening 4
- Cancer-related Molecular Pathways 2
- HER2/EGFR in Cancer Research 2
-
- Breast Lesions and Carcinomas 4
- Co-authors
- Angelo Sidoni (8 shared papers)Guido Bellezza (8 shared papers)Antonio Cavaliere (8 shared papers)E Bucciarelli (6 shared papers)Rino Vitali (3 shared papers)Tiziana Cassetti (6 shared papers)Francesco La Rosa (5 shared papers)Stefania Gori (1 shared paper)
In The Last Decade
Massimo Scheibel
14 papers receiving 272 citations
Peers
Comparison fields: 5 of 40
- Cancer Research 142
- Oncology 182
- Pathology and Forensic Medicine 87
- Dermatology 19
- Pulmonary and Respiratory Medicine 57
Countries citing papers authored by Massimo Scheibel
This map shows the geographic impact of Massimo Scheibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Scheibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Scheibel more than expected).
Fields of papers citing papers by Massimo Scheibel
This network shows the impact of papers produced by Massimo Scheibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Scheibel. The network helps show where Massimo Scheibel may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Scheibel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 106 | |
| 2 | 2002 | 35 | |
| 3 | 2004 | 32 | |
| 4 | 2004 | 30 | |
| 5 | 2006 | 26 | |
| 6 | Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization. | 2006 | 14 |
| 7 | 2003 | 10 | |
| 8 | Urban-rural differences in gynaecological cancer occurrence in a central region of Italy: 1978-1982 and 1998-2002. | 2007 | 10 |
| 9 | Recent trends in incidence, mortality and survival after cancer of the female breast and reproductive organs. Umbria, Italy: 1978-2005. | 2010 | 8 |
| 10 | Incidence of multiple primary malignancies in women diagnosed with breast cancer. | 2009 | 6 |
| 11 | 2008 | 5 | |
| 12 | 2004 | 3 | |
| 13 | 2007 | 3 | |
| 14 | 2007 | 2 |
About Massimo Scheibel
Massimo Scheibel is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Biotechnology and Dermatology, having authored 14 papers that have together received 290 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Global Cancer Incidence and Screening (4 papers), Breast Lesions and Carcinomas (4 papers), Multiple and Secondary Primary Cancers (3 papers), Cancer-related Molecular Pathways (2 papers), Male Breast Health Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (142 citations), Oncology (182 citations), Pathology and Forensic Medicine (87 citations), Dermatology (19 citations) and Pulmonary and Respiratory Medicine (57 citations). Massimo Scheibel has collaborated with scholars based in Italy and Canada. Frequent co-authors include Angelo Sidoni, Guido Bellezza, Antonio Cavaliere, E Bucciarelli, Rino Vitali, Tiziana Cassetti, Francesco La Rosa, Stefania Gori, Lorenza Pistola and Liliana Minelli. Their work appears in journals such as The Breast, Cancer Letters, Lung Cancer, Pathology - Research and Practice and Tumori Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.